Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
- 20 January 2021
- journal article
- research article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 44, 105-120
- https://doi.org/10.1016/j.euroneuro.2021.01.004
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Bildung und Forschung (01EE1402F, 01GV0614)
- South London and Maudsley NHS Foundation Trust
- Medical Research Council (G0901874, MR/M021475/1)
- National Institute for Health and Care Research
- King's College London
- Deutsche Forschungsgemeinschaft (44541416 – TRR 58, SFB 1193 Z03)
This publication has 64 references indexed in Scilit:
- Human fear reconsolidation and allelic differences in serotonergic and dopaminergic genesTranslational Psychiatry, 2012
- Therapygenetics: the 5HTTLPR and response to psychological therapyMolecular Psychiatry, 2011
- Cost of disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- The size and burden of mental disorders and other disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of DepressionJAMA, 2009
- Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR)Molecular Psychiatry, 2008
- 5‐HTTLPR genotype and anxiety‐related personality traits: A meta‐analysis and new dataAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2008
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderAmerican Journal of Human Genetics, 2006
- Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531Molecular Psychiatry, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986